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During the development of vertebrate neuromuscular
junction (NMJ), agrin stabilizes, whereas acetylcho-
line (ACh) destabilizes AChR clusters, leading to the
refinement of synaptic connections. The intracellular
mechanism underlying this counteractive interaction
remains elusive. Here, we show that caspase-3, the
effector protease involved in apoptosis, mediates
elimination of AChR clusters. We found that cas-
pase-3 was activated by cholinergic stimulation of
culturedmuscle cells without inducing cell apoptosis
and that this activation was prevented by agrin.
Interestingly, inhibition of caspase-3 attenuated
ACh agonist-induced dispersion of AChR clusters.
Furthermore, we identified Dishevelled1 (Dvl1), a
Wnt signaling protein involved in AChR clustering,
as the substrate of caspase-3. Blocking Dvl1 cleav-
age prevented induced dispersion of AChR clusters.
Finally, inhibition or genetic ablation of caspase-3
or expression of a caspase-3-resistant form of Dvl1
caused stabilization of aneural AChR clusters.
Thus, caspase-3 plays an important role in the elimi-
nation of postsynaptic structures during the devel-
opment of NMJs.
INTRODUCTION
The clustering of neurotransmitter receptors is a hallmark for
postsynaptic differentiation. At the vertebrate neuromuscular
junction (NMJ), the clustering of acetylcholine receptors (AChRs)
is believed to be regulated by positive and negative factors,
which determine strengthening of innervated AChR clusters
and dispersion of aneural clusters, respectively (Lin et al.,
2001; Sanes and Lichtman, 1999, 2001). The interplay between
positive and negative signals results in the precise matching of
motor nerve terminals to individual postsynaptic sites enriched
with AChRs.
Genetic evidence suggests that postsynaptic AChR clustering
is initiated by a nerve-independent mechanism and is prepat-
terned with the muscle at early developmental stages (Lin670 Developmental Cell 28, 670–684, March 31, 2014 ª2014 Elsevieret al., 2001; Yang et al., 2001). Afterward, the navigating nerve
terminals release a glycoprotein agrin, which acts through its
newly identified receptor LRP4 (Kim et al., 2008; Zhang et al.,
2008), leading to the activation of muscle specific kinase
(MuSK) and the subsequent formation of new clusters or stabili-
zation of the existing clusters (McMahan, 1990; Sanes and Licht-
man, 1999, 2001). Several molecules have been shown to be
involved in agrin/MuSK signaling and AChR clustering, including
AChR-associated protein rapsyn, MuSK binding proteins Dok7,
Dishevelled1 (Dvl1), geranylgeranyltransferase I (GGT), Abl ki-
nase, andRho family of small GTPases (Finn et al., 2003; Gautam
et al., 1995; Luo et al., 2002, 2003; Okada et al., 2006; Weston
et al., 2000; Wu et al., 2010). Meanwhile, motor neurons release
negative signals to disperse the AChR clusters that are not
innervated by nerves. Recent evidence suggests that neuro-
transmitter ACh acts as a negative signal that disperses AChR
clusters and agrin acts to stabilize AChR clusters through coun-
teracting the dispersing activity of ACh (Kummer et al., 2006; Lin
et al., 2005; Misgeld et al., 2005). The mechanism of ACh action
in dispersing AChR clusters is just beginning to be understood
(Chen et al., 2007; Fu et al., 2005; Lin et al., 2005; Yang et al.,
2011). However, the intracellular interplay between positive
and negative signaling remains elusive. Here, we provide evi-
dence showing that caspase-3 acts as a mediator in inducing
the dispersion of AChR clusters via the cleavage of MuSK
signaling protein Dvl1.
Caspase-3 is one of the effector proteases that are usually
known as mediators of cell death (Earnshaw et al., 1999; Troy
and Salvesen, 2002; Yuan and Yankner, 2000). Growing lines of
evidence, however, suggest that caspases are more than just
cell killers, rather they play critical roles in various, nonapoptotic
aspects of normal cellular functions via specific and limited pro-
teolysis (Fadeel et al., 2000; Los et al., 2001; McLaughlin, 2004).
In nerve system, apoptoticmechanisms havebeenconsidered to
be involved in regulating the structural and functional plasticity of
neuronal circuits under physiological conditions (Campbell and
Holt, 2003; Gilman and Mattson, 2002; Gulyaeva et al., 2003;
Huesmann and Clayton, 2006; Mattson and Duan, 1999;
McLaughlin, 2004; Ohsawa et al., 2010). For example, caspases
have been shown to be involved in dendritic pruning (Kuo et al.,
2006; Williams et al., 2006), axon pruning (Nikolaev et al.,
2009), or growth cone dynamics (Campbell and Holt, 2003),
without causing full apoptotic cascades. Moreover, activation
of caspase-3 has been shown to modulate neuronal excitabilityInc.
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et al., 2010; Lu et al., 2002). Nevertheless, the role of caspase-3
during synapse development remains unknown.
Here, we have demonstrated an unexpected role of caspase-3
in the refinement of neuromuscular synapses, uncovering
another nonapoptotic role of caspase-3 in synaptic pruning dur-
ing early development.
RESULTS
Activation of Caspase-3 by Cholinergic Stimulation of
Cultured Muscle Cells
Nerve-derived ACh has been shown to be responsible for the
elimination of AChR clusters that are not stabilized by agrin
(Lin et al., 2005; Misgeld et al., 2005) (Figure 1A). Interestingly,
we found that treatment with carbachol (CCh), a nonhydrolyz-
able cholinergic agonist at a concentration (0.1 mM) that is suffi-
cient to induce the dispersion of AChR clusters in C2C12
myotubes (Chen et al., 2007; Lin et al., 2005), caused an increase
in the level of cleaved caspase-3, the active form of caspase-3,
indicating that CCh may activate caspase-3 (Figure 1B). This
effect peaked around 30 min after CCh treatment and declined
thereafter (Figure 1B). Next, we determined caspase-3 activity
by a more direct assay using Ac-DEVD-pNA as the substrate.
As shown in Figure 1C, CCh stimulation caused a gradual in-
crease in caspase-3 activity. Of note, the same (0.1 mM) or over-
dose (0.3 mM) CCh treatment failed to cause C2C12 muscle cell
apoptosis and thus had no effect on cell health (Figures S1A and
S1B available online), probably because of limited and localized
activation of caspase-3. As a control, treatment with Staurospor-
ine (1 mM), a natural product with apoptosis-inducing activity
(Zhang et al., 2003), caused marked cell apoptosis, as indicated
by a marked increase in the percentage of condensed nuclei
(Figure S1A and S1B).
To further determine the specificity of the observed changes in
caspase-3 activity, we did the analyses in caspase-3 mutant
muscle cells. We found that the bands of active caspase-3 or
activity of caspase-3 were not observed in muscle cells derived
from caspase-3-deficient mice (caspase-3/) (Kuida et al.,
1996), even after treatment with Staurosporine, suggesting the
specificity of the antibody and the Ac-DEVD-pNA probe (Figures
S1C and S1D). The effect of CCh on caspase-3 activity was
abolished when muscle cells were pretreated with agrin, cas-
pase-3 inhibitor Ac-DEVD-CMK (DEVD), or caspase-9 inhibitor
Z-LEHD-FMK (LEHD), but not with caspase-8 inhibitor Z-IETD-
FMK (IETD) (Figure 1D), suggesting complex signaling cascades
in regulating caspase-3 activity. Indeed, caspase-3 activity,
measured by staining with either active caspase-3 antibody (Fig-
ure 1E) or a fluorescence substrate FITC-DEVD-FMK (Figure 1F),
was spatially distributed in regions enriched with AChR clusters
in myotubes treated with CCh (0.1 mM, 1 hr) but was not
observed in muscle cells exposed to agrin (10 ng/ml) (Figures
1E and 1F). In contrast, treatment with Staurosporine (1 mM)
caused an increase in caspase-3 activity throughout the whole
cell in wild-type, but not in caspase-3/ muscle cells (Figures
S1E and S1F). These results may explain why CCh treatment
failed to cause cell apoptosis.
Next, we determined active caspase-3 signals at the stage
when aneural clusters are refined in diaphragms of mice at em-Develobryonic day 16 (E16) and found that active caspase-3wasdistrib-
uted in regions with aneural AChR clusters (Figure 1G). We also
compared intensity of active caspase-3 that was associated
with neural and aneural AChR clusters in motoneuron-muscle
coculture system. Isolated motor neurons, which were positively
stainedwithHB9antibody (Figure S1G), from rat spinal cordwere
transfected with mCherry-tagged-Channelrhodopsin-2 (ChR2),
a light-gated cation channel used to control neuronal activity
(Figure S1H) (Nagel et al., 2002, 2003), and cocultured with fully
differentiated myotubes (Figure 1H). After 2 hr blue light-pulse
treatment, we determined the intensity of active caspase-3 in
muscle cells and found that regions with aneural AChR clusters
exhibited higher caspase-3 activity, compared to background
or regions with innervated clusters in wild-type (Figures 1H
and 1J), but not in caspase-3/ muscle cells (Figure S1I). In
contrast, in cultures without light stimulation, the intensity of
active caspase-3 in either neural or aneural cluster regions was
similar with that of the background (Figures 1H and 1J). These
results suggest that evoked neuronal activity of presynaptic
nerves, via stimulating the release of neurotransmitter ACh,
causes an elevation of nonsynaptic caspase-3 activity in muscle
cells and that caspase-3 is locally inhibited by nerve-derived
factors, such as agrin. In line with this hypothesis, the light-
induced increase in activated caspase-3 associatedwith aneural
clusters was not observed in muscle cells cultured with ChR2
motor neuronswith the downregulation of choline acetyltransfer-
ase (ChAT), the enzyme responsible for the synthesis of ACh
(Santamaria et al., 2009) (Figures 1H–1J). The spatial activity of
caspase-3 associated with aneural AChR clusters may be due
to the recruitment of caspase-3 or its regulatory machinery to
postsynaptic structures.
Caspase-3 Activation Promotes the Dispersion of AChR
Clusters
The activity of caspase-3 associated with aneural AChR clusters
(Figures 1G–1J) and the activation of caspase-3 by cholinergic
stimulation (Figures 1B–1F) raised the possibility for a role of
caspase-3 in mediating the elimination of AChR clusters. To
determine this possibility, C2C12 myotubes were first treated
with agrin (10 ng/ml, 12 hr) to induce the formation of AChR clus-
ters and then switched to agrin-free medium in the presence of
CCh (0.1 mM) with or without DEVD (20 mM) for additional 2 hr
(Figure 2A). We found that CCh treatment promoted elimination
of AChR clusters, as reflected from reduced total length and
number of clusters (Figures 2B–2D), in agreement with early re-
ports that CCh destabilizes AChR clusters (Lin et al., 2005; Mis-
geld et al., 2005). Interestingly, the dispersing effect of CCh was
ameliorated in DEVD-treated cells (Figures 2A–2D), suggesting
that caspase-3 may mediate ‘‘cholinergic’’ agonist-induced
elimination of AChR clusters.
With the concern for the potential side effect of pharmacolog-
ical treatment, we next determined the role of caspase-3 by
analyzing muscle cells derived from caspase-3 mutant mice.
The activity of agrin in inducing the formation of AChR clusters
was similar in caspase-3+/ and caspase-3/ muscle cells,
excluding the involvement of caspase-3 in the formation of
AChR clusters (Figures 2E–2G). Next, we evaluated the stability
of AChR clusters. After treatment with CCh (0.1 mM), AChR clus-
ters on caspase-3+/muscle cells were progressively dispersedpmental Cell 28, 670–684, March 31, 2014 ª2014 Elsevier Inc. 671
Figure 1. Cholinergic Stimulation Activates Caspase-3
(A) Schematic illustration of two overlapping steps in NMJ development.
(B) C2C12 myotubes were treated without (control) or with 0.1 mM carbachol (CCh) for indicated time. Cell lysates (50 mg of protein) were subjected to
immunoblotting (IB) with indicated antibodies. Relative intensity of active caspase-3 was shown underneath the blot.
(C) C2C12 myotubes were treated with 0.1 mMCCh for indicated time. Caspase-3 activity from same amount of cell lysates was determined by using Ac-DEVD-
pNA as the substrate, with the value obtained from control samples normalized as 1. Data are shown asmean ± SEMof three independent experiments. *p < 0.05,
**p < 0.01; ANOVA with Tukey’s post hoc tests.
(D) C2C12 myotubes were treated with caspase-3 inhibitor Ac-DEVD-CMK (DEVD, 20 mM), caspase-8 inhibitor Z-IETD-FMK (IETD, 20 mM), caspase-9 inhibitor
Z-LEHD-FMK (LEHD, 20 mM), or agrin (10 ng/ml) for 30min prior to the stimulation with CCh (0.1 mM, 30min). Caspase-3 activity was determined as shown in (C).
Percentage of CCh-induced caspase-3 activity after various treatments is shown as mean ± SEM from three independent experiments. ***p < 0.001, **p < 0.01,
*p < 0.05; ANOVA with Tukey’s post hoc tests. The mean value of increased caspase-3 activity after CCh stimulation was taken as 100% (Ctrl).
(legend continued on next page)
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ened in caspase-3/ muscle cells (Figures 2F and 2G). These
results support the notion that caspase-3 is involved in
‘‘cholinergic’’ stimulation-induced dispersal of AChR clusters.
To further determine the role of caspase-3 in dispersing AChR
clusters in vivo, we analyzed neuromuscular phenotype of
caspase-3 mutant mice (Kuida et al., 1996). The caspase-3/
mice bred from heterozygotes (Casps3+/) on the C57BL/6
mice background can survive at least 6 months. As shown in
several previously studies, wild-type and mutant littermates did
not differ grossly in the brain and spinal cord (Le et al., 2002;
Oppenheim et al., 2001). We analyzed NMJ development of em-
bryonic mice by staining diaphragms for patterns of pre- and
postsynaptic markers, synaptophysin, and AChRs, respectively.
Notably, although Casps3/ mice at E15 exhibited normal pre-
synaptic differentiation (Figures 2H and 2J), the percentage of
aneural AChR clusters was higher in Casps3/ compared to
wild-type littermates (Casps3+/+) (Figures 2H and 2I). This result
supports again that caspase-3 is involved in the dispersion of
aneural AChR clusters.
Dvl1 as the Substrate of Caspase-3
Next, we asked how caspase-3 activation executed a cluster
dispersing effect. We searched for postsynaptic proteins that
contain conserved caspase-3 cleavage site ‘‘DXXD’’ (Thornberry
et al., 1997) and noted that Dvl1 and b-catenin, which bind to
MuSK and rapsyn (Luo et al., 2002; Zhang et al., 2007a), respec-
tively, are potential caspase-3 targets. Interestingly, the cleavage
site of Dvl1 resides in the DEP domain, which mediates
interactionwithMuSKand is essential for AChRcluster formation
(Jing et al., 2009; Luo et al., 2002) (Figure 3A). To determine
whether cholinergic stimulation induces the cleavage of Dvl1,
we detected levels of cleaved fragment of Dvl1 using an antibody
raised against C terminus of Dvl1 (Luo et al., 2002).We found that
CCh treatment caused a marked increase in the level of 32 kDa
cleaved Dvl1 fragment (Figure 3B, lanes 1–3; Figures 3C and
S2B), with the band size equivalent to predicated cleavage prod-
uct by caspase-3 (Figure 3A). This cleavage was prevented by
pretreatment with agrin (10 ng/ml), DEVD (20 mM), or TAT-Dvl1
(40 mM), a cell-penetrating peptide composed of the TAT
sequence derived from the transactivator of transcription of hu-
man immunodeficiency virus (Nagahara et al., 1998) and the cas-
pase-3 cleavage site of Dvl1 (Figures 3B, lanes 4–6, and 3C), but
not by same amount (40 mM) of the TAT peptide fused with
scrambled sequence (TAT-Scr) (Figure S2A, compare lanes 3(E) C2C12myotubes were treated with CCh (0.1 mM), without or with agrin (10 ng/
and R-BTX for AChR clusters. Scale bar, 5 mm.
(F) C2C12myotubes were treated with 0.1mMCCh, either alone or together with a
FMK. AChR clusters were marked by R-BTX. Scale bar, 5 mm.
(G) E16 mice diaphragms were whole-mount stained with antibodies against acti
signals of active caspase-3 associated with an aneural AChR cluster. Scale bar,
(H) Motor neurons transfected with ChR2-mCherry, without or with siRNA agains
myotubes. After blue light stimulation, cultures were stained with R-BTX and act
least 5 mm away from motor axons, are indicated by yellow and white arrows, re
(I) Efficiency of siChAT in cultured motoneurons. ***p < 0.001, Student’s t test (si
(J) Spatial caspase-3 activity in nerve-muscle coculture system. Data are presente
against background regions from three experiments (numbers ofmuscle cells: 22 f
siChAT with light). ***p < 0.001, **p < 0.01; N.S., not significant; two-way ANOVA
See also Figure S1.
Develoand 4). Other evidence supporting that the 32 kDa fragment
was indeed derived from caspase-3 cleavage of Dvl1 came
from observations that the cleaved fragment was markedly
decreased in caspase-3/ muscle cells compared to that of
wild-typemuscle cells (Figure S1C) and that it was barely detect-
able in mutant muscle cells with Dvl1 downregulation (Fig-
ure S2B). We observed no apparent cleavage of b-catenin in
muscle cells with either CCh (0.1 mM, 1 hr) or Staurosporine
(1 mM, 2 hr) treatments (Figures S2C and S2D). Thus, cholinergic
activation induces the caspase-3-mediated truncation of Dvl1.
The specificity of TAT-Dvl1 peptide in inhibiting Dvl1 cleavage
was further determined by probing Akt, another substrate of
caspase-3, which has been shown recently to be involved in
caspase-3-mediated LTD induction (Li et al., 2010). We treated
C2C12 myotubes with 0.1 mM CCh or 1 mM Staurosporine and
found that both treatments caused activation of caspase-3 and
induced the cleavage of Akt (Figures 3D and 3E). Notably, the
Akt cleavage was prevented by pretreatment with DEVD, but
not by TAT-Dvl1 (Figure 3D, compare lanes 3 and 4 and 6
and 7; Figure 3E). The selective effect of TAT-Dvl1 may be deter-
mined by different spatial localization of substrates or enzyme-
substrates affinities. The effectiveness of TAT-Dvl1 was further
determined in a cell-free system with purified active caspase-3
added to muscle cell lysates, which contain endogenous Dvl1.
As expected, incubation with caspase-3 caused a decrease in
the level of full-length Dvl1 and an increase in the level of cleaved
Dvl1 (Figures 3F, lanes 1–3, and 4I, lanes 1 and 2; Figure S2E,
compare lanes 1 and 3), indicating the cleavage of Dvl1 by
caspase-3. Remarkably, this cleavage was inhibited in the pres-
ence of TAT-Dvl1 peptide (Figure 3F, compare lanes 3 and 4;
Figure S2E, compare lanes 3 and 4). Notably, in this cell-free sys-
tem, caspase-3 treatment of lysates from Dvl1 knockdown cells
did not cause the elevation of the 32 kDa band (Figure S2E,
compare lanes 2 and 3), indicating again the specificity of Dvl1
cleavage by caspase-3.
Blocking Dvl1 Cleavage Prevents the Dispersion of
AChR Clusters
Next, we used the TAT-Dvl1 peptide to block the caspase-3
cleavage of Dvl1 and determined its effect on the stability of
AChR clusters. As shown in Figure 4A, the role of CCh
(0.1 mM, 1 hr) in inducing cluster dispersion was markedly pre-
vented in myotubes pretreated with TAT-Dvl1 (40 mM, 0.5 hr),
but not by TAT-Scr. The antidispersing effect was reflected in
rescued number or total length of AChR clusters (Figures 4Bml) for 1 hr, followed by staining with antibody against active form of caspase-3
grin (10 ng/ml), for 1 hr, and activity of caspase-3 was detected by FITC-DEVD-
ve caspase-3 and Smi-312, and R-BTX for AChR clusters. The arrow indicates
10 mm.
t ChAT (siChAT) or scrambled sequence (siCtrl), were cocultured with C2C12
ive caspase-3 antibody. Innervated and aneural AChR clusters, which were at
spectively. Scale bar, 10 mm.
Ctrl, n = 12; siChAT, n = 10 cells). Scale bar, 20 mm.
d asmean ± SEM for relative levels of active caspase-3 in AChR cluster regions
or control without light, 22 for control with light, 27 for siCtrl with light, and 34 for
with Tukey’s post hoc tests or Student’s t test.
pmental Cell 28, 670–684, March 31, 2014 ª2014 Elsevier Inc. 673
Figure 2. Inhibition or Genetic Ablation of Caspase-3 Stabilizes AChR Clusters
(A) Increased stability of AChR clusters in DEVD-treated muscle cells. C2C12 myotubes were stimulated with agrin (10 ng/ml, 12 hr) to induce the formation of
AChR clusters and then switched to agrin-free medium, followed by the treatment with CCh (0.1 mM, 2 hr) in the presence or absence of DEVD (20 mM). AChR
clusters were visualized by R-BTX. Shown are images from a representative experiment that was repeated three times with similar results. Scale bar, 50 mm.
(B–D) Quantitative analyses of AChR cluster size (B) and numbers (C) per 100 mmmyotubes or numbers per 1mm2 (D) obtained from experiments described in (A).
Data are shown as mean ± SEM from three experiments. **p < 0.01, ***p < 0.001; ANOVA with Tukey’s post hoc tests (numbers of myotubes from three
experiments: 91 for control, 74 for DEVD, 91 for CCh, and 93 for CCh+DEVD).
(E) Increased stability of AChR clusters in caspase-3 mutant muscle cells. Primary muscle cells isolated from different caspase-3 mutant mice (+/ or/) were
treated with agrin (10 ng/ml, 12 hr) to induce the formation of AChR clusters and switched to agrin-free medium. Myotubes were then treated with CCh (0.1 mM)
for different times (1–2 hr). Shown are images from a representative experiment that was repeated three times with similar results. Scale bar, 20 mm.
(legend continued on next page)
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sion of AChR clusters, probably through the cleavage of Dvl1.
Given the local activity of caspase-3 associated with aneural
AChR clusters (Figures 1E–1J), we determined the effect of
TAT-Dvl1 on the stability of AChR clusters in motoneuron-
muscle coculture system, where neuronal activity could be
manipulated by light-gated ChR2. Notably, blue light-pulse stim-
ulation resulted in a marked decrease in the number or length of
aneural AChR clusters (Figures 4D–4F). Interestingly, this light-
induced cluster dispersion was largely prevented by pretreat-
ment with TAT-Dvl1, but not with TAT-Scr (Figures 4D–4F).
These results can be interpreted as that activity-triggered synap-
tic ACh release causes the onset of electrical activity in postsyn-
aptic muscle cells, leading to caspase-3 activation, cleavage of
Dvl1, and finally the dispersion of AChR clusters.
To further confirm the role of Dvl1 as the functional substrate of
caspase-3 in dispersing AChR clusters, we generated lentivirus
constructs, which drive expression of wild-type or a mutated
form of Dvl1 (Dvl1res) and thus should be resistant to caspase-3
cleavage; the caspase-3 cleavage site ‘‘DVVD’’ was changed to
‘‘AVVA’’ (Figure 4G). The Dvl1 proteins expressed well in infected
myotubes, with wild-type and mutant at comparable levels (Fig-
ure 4H). The Dvl1res was resistant to caspase-3 cleavage in a
cell-free system (Figure 4I, lanes 3 and 4), whereas the wild-
type Dvl1 (Dvl1wt) was very sensitive to caspase-3 (Figure 4I,
lanes 1 and 2). We found that the expression of Dvl1res had no
effect on the formation of AChR clusters, whereas it stabilized
AChR clusters under the condition with CCh treatments, with
an effect more significant than that caused by Dvl1wt (Figures
4J–4L). These results support the notion that Dvl1 cleavage by
caspase-3 mediates ACh-induced dispersion of AChR clusters.
Next, we determined effects of Dvl1 overexpression in vivo by
injecting lentivirus encoding mutant or wild-type Dvl1 into the
chest of embryonic mice at E14. The empty lentivirus construct
encoding GFP was coinjected to mark infected muscle cells in
diaphragms (Figure 4M). Four days after virus injection, E18
mice diaphragms were stained for patterns of AChR clusters
and axons, which were labeled by Smi-312 antibody (Figure 4M).
Given the chimeric expression of target proteins in muscle
cells, we only analyzed GFP-positive myotubes. We found that
Dvl1res-expressing muscles exhibited a marked increase in the
percentage of aneural AChR clusters, compared to control or
Dvl1wt groups (Figure 4N). In addition, the endplate width was
bigger in Dvl1res-infected animals than that of other two groups
(Figure 4O). These results have provided strong evidence sup-
porting the conclusion that Dvl1 acts as a key substrate of cas-
pase-3 inAChRcluster disassembly following innervations invivo.
Inhibition or Genetic Ablation of Caspase-3 Rescues
AChR Clusters in Agrin Mutant Mice
It is believed that agrin stabilizes innervated AChR clusters by
counteracting the dispersing role of ACh (Lin et al., 2005;Misgeld(F and G) Quantitative analysis of size (F) and number (G) of AChR clusters in (E). D
t test.
(H) Diaphragm muscles from E15 Casps3+/+ or Casps3/mutant mice were stain
indicate aneural clusters. Scale bar, 20 mm.
(I) Percentage of the aneural AChR clusters among total clusters. Data are shown
(J) Quantification for the area of synaptophysin distribution. Data are shown as m
Develoet al., 2005). To circumvent the interference of agrin action on
caspase-3, we chose to inhibit or delete caspase-3 in agrin
mutant mice and then determined the stability of AChR clusters.
First, we injected DEVD into the chest of E14 mice to suppress
caspase-3 activity in the diaphragms. E17 diaphragm muscles
of agrin mutant (agrin/) mice (Burgess et al., 1999) were
stained for presynaptic motor nerve terminals and postsynaptic
AChR clusters. By E17, most prepatterned aneural AChR clus-
ters should have been eliminated (Sanes and Lichtman, 2001).
As expected, only a few AChR clusters were present in the mus-
cle of agrin/ mice injected with vehicle DMSO (Figure 5A, top
row). However, numerous AChR clusters were observed when
agrin/ mice were treated with DEVD (Figure 5A, bottom row).
Interestingly, most of these AChR clusters were not apposed
by nerve terminals (Figure 5A). Quantitatively, both average
area of individual clusters and the number of clusters were signif-
icantly increased in DEVD-treated agrin/ mice compared to
those observed in DMSO-treated agrin/ mice (Figures 5B
and 5C). These results support the notion that activation of
caspase-3 participates in the elimination of AChR clusters.
Second, we determined the NMJ phenotypes of caspase-3
mutants in the background of agrin knockout. Interestingly,
when agrin mutant mice (agrin/) were crossed with casps3/
mice, the loss of AChR clusters was markedly rescued (Figures
5D–5F; Figure S3A). Numerous AChR clusters were observed
in agrin/; Casps3/ mice, in comparison to a few clusters in
agrin/; Casps3+/mice at E17 (Figures 5D and 5E) or E15 (Fig-
ures S3A and S3B). The size of AChR clusters were also
increased in agrin/; Casps3/ mice at E17 (Figure 5F), but
not at E15 (Figure S3C). Similar to that caused by DEVD
treatment, most rescued clusters were not apposed to synapto-
physin-labeled nerve terminals (Figure 5D, see magnified areas;
Figure S3A) and distribution of axons was similar between two
groups (Figures S3D and S3E). Of note, these clusters were
colocalized with some synaptic proteins, such as laminin b2 or
rapsyn (Figure S3F). These results indicate that caspase-3 inhi-
bition increased stability of aneural AChR clusters in the skeletal
muscle but had no effect on gross axon distribution.
Besides defects in postsynaptic differentiation, agrin knock-
outs also exhibit poor differentiation of presynaptic structures,
including lack of synaptic vesicles in motor axons, which are
loosely associated with Schwann cells (Gautam et al., 1996).
To gain deep insights into the ultrastructure of NMJs in
caspase-3 and agrin double knockout mice, we did electron
microscopy (EM) analysis for wild-type and mutant mice. As
shown in Figure 5G (top row), muscles of wild-type mice at
E17were normally innervated by axons (Ax) that contained accu-
mulations of synaptic vesicles, and occasionally active zones,
and were usually wrapped by electron dense Schwann cell
(Sc) processes. It is known that at this stage the postsynaptic
structures are premature and junctional folds are difficult to
discern (Desaki and Uehara, 1987; Sanes and Lichtman, 1999).ata are shown as mean ± SEM from three experiments. ***p < 0.001; Student’s
ed with antibody against synaptophysin and R-BTX for AChR clusters. Arrows
as mean ± SEM from three mice in each group. ***p < 0.001, Student’s t test.
ean ± SEM from three mice in each group. Student’s t test.
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Figure 3. Dvl1 as the Substrate of Caspase-3
(A) Schematic representation of Dvl1 structure and the potential caspase-3 cleavage site. Dvl is composed of three domains: DIX (Dishevelled-Axin), PDZ, and
DEP (Dishevelled-Egl-10-Pleckstrin). The conserved cleavage site of caspase-3 resides within the DEP domain.
(B) C2C12 myotubes were pretreated with agrin (10 ng/ml), DEVD (20 mM), or TAT-Dvl1 peptide (40 mM) for 0.5 hr, followed by treatment with 0.1 mM CCh
for the indicated time. Cell lysates were subjected to IB with antibody that recognizes C terminus of Dvl1 or active caspase-3 or GAPDH as the loading
control.
(C) Quantification for the Dvl cleavage. The ratio for the intensity of cleaved Dvl and full-length Dvl was analyzed in each set of experiment with the value of 60min
CCh group normalized as 1.0. Data are presented as mean ± SEM of three experiments. *p < 0.05, ANOVA with Tukey’s post hoc tests.
(D) C2C12 myotubes were pretreated with DEVD (20 mM) or TAT-Dvl1 peptide (40 mM) for 0.5 hr, followed by treatments with 0.1 mM CCh for 1 hr or 1 mM
Stauosporine for 3 hr. Cell lysates were subjected to IB with anti-AKT antibody, which recognizes total and cleaved AKT, or antibody recognizing active
caspase-3.
(E) Quantification for the cleavage of AKT. The ratio for the intensity of cleaved Akt and total Akt was analyzed in each set of experiment with values from
Staurosporine or CCh alone normalized as 1.0. Data are shown as mean ± SEM from three experiments. *p < 0.05; ***p < 0.001; ANOVA with Tukey’s post
hoc tests.
(F) C2C12 muscle cell lysates (100 mg proteins in 20 ml NP40 buffer with 10% glycerol) were incubated at 37C with indicated amount of caspase-3 for 16 hr,
without or with TAT-Dvl1 peptide (4 mM), and then subjected to IB with anti-Dvl1 antibody. Shown is a representative result with numbers underneath blots
indicating relative intensity of full-length (top row) and cleaved Dvl1 (bottom row) with the value without caspase-3 normalized as 1.
See also Figure S2.
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Caspase-3 in Synapse EliminationIn agreement with the previous report (Gautam et al., 1996),
agrin/mice showed severe defects in synaptic differentiation,
including the lack of vesicles and the loose association of
Schwann cells with axon terminals (Figure 5G, middle row).676 Developmental Cell 28, 670–684, March 31, 2014 ª2014 ElsevierInterestingly, the axon structures were better preserved in
agrin/; caspase-3/ mice, as evidenced by the appearance
of numerous vesicles in axon terminals, which abutted myotube
membranes (Figure 5G, bottom row). Sometimes, multiple axonInc.
Figure 4. Blocking Dvl1 Cleavage Prevents Dispersion of AChR Clusters
(A) C2C12myotubes were first treated with agrin (10 ng/ml) for 12 hr and then switched to agrin-free medium, followed by treatment with 0.1 mMCCh, without or
with TAT-Dvl1 (40 mM) or the same amount of scrambled peptides (TAT-Dvlscr), for additional 1 hr. AChR clusters were marked by R-BTX. Scale bar, 50 mm.
(B and C) Quantification for the number (B) and total length (C) of AChR clusters. Data are shown as mean ± SEM from three experiments. ***p < 0.001;
ANOVA with Tukey’s post hoc tests. The numbers of myotubes from three experiments are 158 for Ctrl, 196 for CCh, 152 for CCh+TAT-Dvl1scr, and 146
for CCh+TAT-Dvl1.
(legend continued on next page)
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Caspase-3 in Synapse Eliminationterminals were observed in close apposition with muscle mem-
branes (Figure 5G, bottom row, right lane). Notably, Schwann
cells were still loosely associated with axons or even absent in
double knockouts (Figure 5G, bottom row). Given the similar pat-
terns of axon distribution (Figures S3D and S3E), the ultrastruc-
tural changes of the NMJs in caspase-3 and agrin double
knockout mice compared to agrin knockout mice were most
likely caused by the rescue of postsynaptic structures, which
may provide retrograde signaling for presynaptic differentiation.
Caspase-3 Cleavage of Dvl1 Affects Postsynaptic
Signaling
Howdoes the prevention of Dvl1 cleavage protect AChR clusters
from being dispersed? Previously, we have shown that Dvl1
interaction with MuSK is important for agrin-induced AChR clus-
tering (Luo et al., 2002). Given that the cleavage site in Dvl1 re-
sides within the DEP domain that mediates the interaction with
MuSK, we determined whether CCh stimulation affects the inter-
action between MuSK and Dvl1. In agreement with our previous
observation (Luo et al., 2002), we found that immunoprecipita-
tion (IP) of Dvl1 caused coIP of MuSK in wild-type muscle cells
(Figure 6A, left). Notably, treatment with CCh (0.1 mM, 2 hr)
caused a decrease in the amount of MuSK associated with
Dvl1, suggesting that ‘‘cholinergic’’ stimulation affects agrin/
MuSK signaling for AChR clustering. Interestingly, the disas-
sembly effect of CCh on MuSK-Dvl1 complex was not observed
in caspase-3/ muscle cells (Figure 6A, right), indicating that
caspase-3 is involved in disrupting the agrin/MuSK signaling.
The tumor suppressor Adenomatous Polyposis Coli (APC)
binds directly to Dvl (Matsumoto et al., 2010) and has been
shown to be critical for the formation and stabilization of AChR
clusters (Wang et al., 2003). We found that agrin treatment
caused clustering of APC, which was colocalized with AChR
clusters (Figure 6B). Interestingly, short-term treatment with
CCh (0.1mM, 0.5 hr) induced dispersion of APC clusters (Figures
6B and 6C), without apparent effect on AChR clusters (Fig-
ure 6B). This result suggests that CCh-induced disassembly of
APC clusters happens early than declustering of AChR clusters.
Interestingly, pretreatment with TAT-Dvl1 (40 mM, 0.5 hr), but not
with TAT-Scr, markedly prevented the dispersal of APC clusters
(Figures 6B and 6C). In addition, overexpression of Dvl1res sta-
bilized APC clusters with a more marked effect than that caused(D) ChR2-expressing motor neurons were cocultured with C2C12 myotubes, follo
or TAT-Scr peptides (40 mM). AChR clusters were marked by R-BTX. Scale bar,
(E and F) Quantification for the number (E) or total length (F) of aneural AChR clu
experiments. N.S., not significant; *p < 0.05, **p < 0.01, ***p < 0.001; ANOVAwith T
for Ctrl no light, 77 for Ctrl with light, 51 for TAT-Scr with light, and 85 for TAT-D
(G) Dvl1res, the mutated form of Dvl1 resistant to caspase-3 cleavage, was subc
(H) Expression of Dvl1 in lentivirus-infected C2C12 myotubes. Note the compara
(I) Lysates of C2C12 myotubes without or with lenti-Dvl1res infection were incu
determine the cleavage of Dvl1.
(J) C2C12myotubes infectedwith control (Ctrl) or lenti-Dvl1were treatedwith agrin
agrin-free medium without or with CCh (0.1 mM) and incubated for additional 1 h
(K and L) Quantification for the number (K) and total length (L) of AChR clusters und
**p < 0.01, ***p < 0.001; ANOVA with Tukey’s post hoc tests. At least 100 muscle
(M) Chests of E14 mice were injected with lentivirus expressing GFP, either alone
dissected out at E18 and whole-mount stained with antibody against Smi-312, G
indicate aneural AChR clusters. Scale bars, 50 mm for top rows, and 20 mm for m
(N and O) Quantification for the percentage of aneural clusters in GFP positive myo
three embryos in each group. *p < 0.05; ANOVA with Tukey’s post hoc tests.
678 Developmental Cell 28, 670–684, March 31, 2014 ª2014 Elsevierby Dvl1wt (Figures 6B and 6C). Thus, the cleavage of Dvl1 at the
DEP domain by caspase-3 affects the stability of AChR clusters,
probably through disassembly of MuSK signaling and/or desta-
bilization of APC clusters.
Agrin Inhibits Caspase-3 and Stabilizes AChR Clusters
through Heat Shock Protein 90
How does agrin regulate caspase-3 activity? It has been shown
that heat shock protein 90b (HSP90b) regulates AChR cluster
formation and maintenance by stabilizing rapsyn (Luo et al.,
2008). Indeed, several heat shock proteins, including HSP70
and 90, are known to execute an antiapoptotic role by inhibiting
caspase-3, directly or indirectly (Garrido et al., 2001). To deter-
mine the relationship between HSP90 and caspase-3 activity,
we treated muscle cells with CCh, in the absence or presence
of agrin, without or with 17-(allylamino)-17-demethoxygeldana-
mycin (17-AAG), an inhibitor of HSP90 (Stebbins et al., 1997).
We found that the inhibitory effect of agrin on CCh-induced
caspase-3 activity was completely prevented by 17-AAG (Fig-
ures 7A and 7B). Furthermore, the protective role of agrin in
CCh-induced AChR cluster dispersion was prevented by 17-
AAG treatment (Figures 7C–7E). The same 17-AAG treatment,
either alone or in the presence of CCh, had no effect on cell
health, as indicated by similar low percentage of condensed
nuclei compared to vehicle control group (Figures S4A and
S4B). To exclude the possible side effect of 17-AAG, we down-
regulated the expression of HSP90b in muscle cells using small
interfering RNAs (siRNAs) (Figure 7F) and found that agrin was
unable to stabilize AChR clusters in HSP90b knockdown cells
(Figures 7G–7I), although downregulation of HSP90b, without
or with CCh treatment, had no effect on cell health (Figures
S4A and S4B). Thus, HSP90b at the NMJ may help to inhibit
caspase-3 locally, in addition to its role in protecting rapsyn,
leading to the stabilization of innervated AChR clusters.
Because HSP90 is reported to bind and suppress apoptotic
protease activating factor 1 (Apaf-1), an adaptor protein essen-
tial for caspase-3 activation in the mitochondria pathway (Pan-
dey et al., 2000; Yuan and Yankner, 2000), we decided to test
the role of Apaf-1 in regulating the stability of AChR clusters.
We found that in muscle cells with the downregulation of
Apaf-1 (Figure S4C), the CCh-induced dispersion of AChR clus-
ters was partially prevented (Figures S4D–S4F), suggesting thatwed by no light or pulse blue-light stimulation for 2 hr, without or with TAT-Dvl1
10 mm.
sters in the innervated myotubes. Data are shown as mean ± SEM from three
ukey’s post hoc tests. The numbers ofmyotubes from three experiments are 69
vl1 with light.
loned into lentivirus vector pLVU-tTR-KRAB.
ble level of Dvl1wt and Dvl1res.
bated with caspase-3 (0.5 mg) for 16 hr, followed by IB with Dvl1 antibody to
(10 ng/ml, 12 hr) to induce the formation of AChR clusters and then switched to
r. AChR clusters were marked by R-BTX. Scale bar, 50 mm.
er indicated conditions. Data are shown asmean ± SEM from four experiments.
cells were analyzed in each experimental condition.
or together with that expressing Dvl1wt or Dvl1res. Diaphragm muscles were
FP, and R-BTX. GFP signal was used to mark infected muscle cells. Arrows
agnified examples (bottom).
tubes (N) and endplate width (O). Data are shown as mean ± SEM from at least
Inc.
Figure 5. Inhibition or Genetic Ablation of Caspase-3 Protects Aneural AChR Clusters
(A) Caspase-3 inhibitor DEVD (15 mg per embryo) or vehicle (DMSO) was injected into the chests of E14 mice. Diaphragmmuscles were dissected out at E17 and
whole-mount stained with antibody against synaptophysin or with R-BTX. Scale bar, 50 mm.
(B and C) Quantification for AChR cluster number (B) and size (C) in agrin mutants injected with DEVD or vehicle. Data are shown as mean ± SEM from at least
three embryos in each group. *p < 0.05; Student’s t test.
(D) Diaphragms from E17 agrin/; Casps3+/ and agrin/; Casps3/ mutant mice were stained with R-BTX and antibody against synaptophysin. Scale
bar, 50 mm.
(E and F) Quantification for the number (E) and size (F) of clusters in the same fields from mutant mice in (D). Data are shown as mean ± SEM from three mice in
each group. **p < 0.01, *p < 0.05; Student’s t test.
(G) Electron microscopy (EM) analysis for wild-type and mutant mice. Sc, Schwann cell; Ax, axon; Mu, muscle. Scale bar, 0.5 mm.
See also Figure S3.
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Caspase-3 in Synapse EliminationApaf-1 is involved in elimination of AChR clusters. Interestingly, it
has been shown that local inhibition of caspase activity by
X-linked inhibitor of apoptosis protein (XIAP) regulates dendrite
pruning (Kuo et al., 2006) and synaptic function during learning
(Huesmann and Clayton, 2006). However, downregulation of
XIAP had no effect on AChR cluster formation or stabilization
(Figures S4G–S4J). Thus, the modulatory mechanisms may be
different in various cellular contexts.DeveloDISCUSSION
Here, we have demonstrated a role of caspase-3 in the elimina-
tion of postsynaptic structures during neuromuscular synapse
refinement. We propose that ACh-activation of caspase-3 is
responsible for the elimination of aneural AChR clusters through
the cleavage of MuSK signaling protein Dvl1. On the other hand,
agrin inhibits ACh-induced activation of caspase-3 to stabilizepmental Cell 28, 670–684, March 31, 2014 ª2014 Elsevier Inc. 679
Figure 6. Caspase-3 Cleavage of Dvl1 Affects Agrin/MuSK Signaling in AChR Clustering
(A) Muscle cells derived fromwild-type (+/+) or caspase-3/micewere treatedwithout or with CCh (0.1mM, 2 hr). Cell lysates were subjected to IP with anti-Dvl1
antibody or control IgG (Ctrl), followed by IB with MuSK or Dvl1 antibody.
(B) C2C12 myotubes, without or with Lenti-Dvl1 infection, were first treated without (control) or with agrin (10 ng/ml) for 4 hr and then switched to agrin-free
medium, followed by treatment with 0.1 mM CCh, without or with TAT-Dvl1 (40 mM), or the same amount of TAT-Scr, for an additional 0.5 hr. Muscle cells were
then stained with APC antibody and R-BTX for AChR clusters. Arrows indicate APC clusters. Scale bar, 10 mm.
(C) Percentage of myotubes with APC clusters. Data are shown as mean ± SEM from three experiments. *p < 0.05, **p < 0.01, ***p < 0.001; ANOVA with Tukey’s
post hoc tests. At least 50 muscle cells were analyzed in each experimental condition.
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Caspase-3 in Synapse Eliminationinnervated AChR clusters, most likely through HSP90b (Fig-
ure 7J). Given that caspase-3 ablation only partially rescued
NMJ defects in agrin mutant mice, it remains possible that there
are other effectors that may be involved in sculpturing postsyn-
aptic structures.
Many caspase substrate proteins, including structure pro-
teins, signal proteins, and some receptors, such as AMPA
receptor subunit GluR1 are localized in pre- or postsynaptic
compartments of neurons (Mattson and Duan, 1999). Strictly
controlled activation of caspases may result in local functional
and morphological alterations without causing cell death. Here,
we found that Dvl1, a Wnt signaling protein that has been shown
to be involved in the formation of AChR, clusters in cultured
muscle cells (Luo et al., 2002) and in the organization of synaptic
prepattern during zebrafish neuromuscular development (Jing
et al., 2009), as the substrate of caspase-3. Interestingly, the
caspase-3 cleavage site of Dvl1 resides in the DEP domain,
which mediates the interaction between Dvl1 and MuSK (Luo
et al., 2002) or APC (Matsumoto et al., 2010). Indeed, the DEP
domain of Dvl is important for AChR cluster formation in cultured
muscle cells (Luo et al., 2002) or prepatterning of zebrafish680 Developmental Cell 28, 670–684, March 31, 2014 ª2014 Elsevierneuromuscular synapses (Jing et al., 2009). Of note, both Dvl
and APC are Wnt signaling proteins, which play an important
role in NMJ development (Wu et al., 2010). Interestingly, Dvl
has been shown to be involved in the stabilization of microtu-
bules through the direct interaction with APC (Matsumoto
et al., 2010) or inhibition of serine/threonine kinases, including
glycogen synthase kinase 3 beta (GSK-3b) (Ciani et al., 2004)
or microtubule affinity regulating kinase 2 (MARK2) (Zhang
et al., 2007b). APC itself is associated with microtubule plus
end (Mimori-Kiyosue and Tsukita, 2001; Zumbrunn et al.,
2001), and interestingly, a recent report shows that capture of
microtubules at the subsynaptic muscle membrane regulates
AChR insertion into the postsynaptic membrane (Schmidt
et al., 2012). The disassembly of APC clusters by CCh suggests
involvement ofmicrotubules in the stabilization of AChR clusters.
The caspase-3 cleavage of Dvl1 may result in changes in the
postsynaptic microtubule structures, leading to destabilization
of AChR clusters. Of note, genetic ablation of Dvl1 only affects
AChR cluster distribution (Henriquez et al., 2008). The subtle
defect observed in Dvl1/ mice might be due to functional
compensation by Dvl2 or Dvl3 (Henriquez et al., 2008).Inc.
Figure 7. Agrin Inhibits Caspase-3 and Stabilizes AChR Clusters through Heat Shock Protein 90
(A) C2C12 myotubes were treated with CCh (0.1 mM) for 1 hr, without or with pretreatment with agrin (10 ng/ml, 0.5 hr), or agrin plus 17-AAG (5 mM, 0.5 hr). Cell
lysates were subjected to IB with indicated antibodies.
(B) Quantification for caspase-3 activity. The ratio of active caspase-3 and loading control was presented with the value of control group normalized as 1.0. Data
are shown as mean ± SEM from three experiments. *p < 0.05; ANOVA with Tukey post hoc tests.
(legend continued on next page)
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Developmental Cell
Caspase-3 in Synapse EliminationSynaptic elimination is a critical step in the establishment of
proper neuronal connections. The role of caspase-3 in elimi-
nating postsynaptic structures during neuromuscular synaptic
refinement will provide further insights into mechanisms underly-
ing central nervous system circuit formation.
EXPERIMENTAL PROCEDURES
Reagents, Constructs, and Mice
All reagents, including antibodies, siRNAs, and constructs, and mice used in
this study are introduced in the Supplemental Experimental Procedures. The
use of animals is in compliance with the guidelines of the Institutional Animal
Care and Use Committee.
Muscle Cell Culture and Treatments
C2C12 muscle cells were cultured as described previously (Luo et al., 2002).
After genotyping, primary muscle cultures were prepared from limb muscles
of neonatal mice and induced to become fully differentiated myotubes, as
described previously (O’Malley et al., 1997). C2C12 or primary myotubes
were treated with indicated reagents, followed by staining with R-BTX for
AChR clusters.
Coculture and Optogenetic Manipulation
Motor neurons were isolated from E14 Sprague-Dawley rats in accordance
with the protocol introduced previously (Leach et al., 2011) with several mod-
ifications. Briefly, Spinal motor neurons were purified from the ventral spinal
cords and dissociated with 0.125% trypsin. After transfection with ChR2-
mCherry, without or with siChAT or siCtrl, by electroporation using the Amaxa
Nucleofector, neurons were plated on differentiated C2C12 cells and main-
tained in Dulbecco’s modified Eagle’s medium supplemented with 3% horse
serum. ChR2-mCherry-expressing motor neurons were stimulated under
pulsed blue light (2 Hz, 10 ms per pulse, 10 pulses per train with 60 s interval)
for 2 hr. Drugs were added into the medium 30 min before stimulation.
Light Activation and Electrophysiology
Awhole-cell recording (in current clamp) of culturedmotor neurons expressing
ChR2 was made with glass micropipettes and an Axopatch 700A amplifier
(Molecular Devices), with a shutter controlling the duration of blue-light stimuli.
See the Supplemental Experimental Procedures for details.
Caspase-3 Activity Assay
After various treatments, total and spatial activity of caspase-3 in cultured
muscle cells was measured with Ac-DEVD-pNA (Beyotime) and FITC-DEVD-
FMK (Calbiochem) as the substrates, respectively. See the Supplemental
Experimental Procedures for details.
Virus or DEVD Injection into Embryonic Mice Chests
Pregnant mice on embryonic day 14 (E14) were anesthetized with sodium
pentobarbital and subjected to abdominal incision to expose the uterus. Fetal
mice chests were injected with drugs (15 mg DEVD or vehicle) or viruses (1.53
106 transducing units of lenti-Dvl1 plus 2 3 105 transducing units of lenti-GFP(C) C2C12 myotubes were treated with agrin (10 ng/ml) for 12 hr and then switc
without or with pretreatment with agrin (10 ng/ml, 0.5 hr), or agrin plus 17-AAG (
(D and E) Quantification for the number (D) and total length (E) of AChR clusters. Da
Tukey’s post hoc tests. The numbers of myotubes from three experiments are 1
(F) C2C12 myotubes were transfected without or with siHSP90b or siScr. After 7
(G) C2C12 cells were transfected with or without siHSP90b or siScr, with cotransf
with agrin (10 ng/ml) for 12 hr and then switched to agrin-free medium, followed
(10 ng/ml, 0.5 hr). AChR clusters were marked by R-BTX. Shown are representa
(H and I) Quantification for the number (H) and total length (I) of AChR clusters in YF
***p < 0.001; ANOVA with Tukey’s post hoc tests. At least 80 muscle cells were
(J) Working model. ACh-activation of caspase-3 leads to the cleavage of MuSK si
inhibits ACh-induced activation through HSP90b, leading to the stabilization of in
See also Figure S4.
682 Developmental Cell 28, 670–684, March 31, 2014 ª2014 Elsevieror lenti-GFP alone) mixed with 3–4 ml 0.05% Fast Green. Three or four days
postinjection, diaphragms of E17 (for DEVD) or E18 (for viruses) mice were
examined by immunohistochemistry.
Immunohistochemistry and Image Analysis
After various treatments, C2C12 myotubes were stained with R-BTX to label
AChRs (Luo et al., 2003). Images were collected with a Zeiss confocal micro-
scope using a 403 objective. The total length of all AChR clusters or number
of clusters bigger than 5 mm in 100 mm myotube were quantitatively
analyzed. For diaphragm samples, the staining procedure was followed as
reported in the previous study (Luo et al., 2003). Synaptic nerve terminals
were marked by staining with anti-synaptophysin antibody. AChR clusters
labeled by R-BTX at the most ventral left side of the diaphragm that has little
anatomical variation across mice were quantitatively analyzed. Numbers of
AChR clusters were analyzed from images taken with a 203 objective,
whereas AChR cluster area was determined from images with a 633 or
603 objective. Area and intensity of fluorescence signals were measured
by Image-Pro Plus with the same fluorescence threshold. We used ImageJ
(NeuronJ) software to trace all the AChR clusters, and clusters smaller
than 5 mm were deleted from the results exported by ImageJ (NeuronJ). All
the images were quantified by researchers who were blinded to experimental
conditions.
Electron Microscopy Analysis
Diaphragms from E17 wild-type or mutant mice were fixed in 2.5% glutaralde-
hyde overnight and then fixed in 1%OsO4, followed by uranyl acetate staining
and dehydration. Samples embedded in resin were sectioned with consecu-
tive slices every 5 mm apart, and ultrathin sections were stained with lead
citrate. Image analysis and acquisition were performed using transmission
electron microscopy (TEM).
Quantitative Analysis
After analysis for the normal distribution and homogeneity of variance among
values of the same set, pooled data were subject to statistical analysis using
ANOVA supplemented with Tukey’s post hoc tests or t tests. All the data
were shown as mean ± SEM from at least three experiments (p < 0.05 is
considered as significant difference).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2014.02.009.
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